Posted by Michael Wonder on 07 Apr 2022
CADTH launches consultations on proposals to enhance drug review processes
4 April 2022 - CADTH has launched consultations on a proposed process for non-sponsored reimbursement reviews and a streamlined process for drug class reviews.
Currently, a sponsor (a drug manufacturer or a provincially recognised tumour group) must initiate a CADTH reimbursement review by filing an application.
